These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 6081657)

  • 21. In-vivo study on the relation between Bridge anticoagulant and antihaemophilic globulin.
    NOUR-ELDIN F; WILKINSON JF
    Br J Haematol; 1958 Jul; 4(3):292-301. PubMed ID: 13572740
    [No Abstract]   [Full Text] [Related]  

  • 22. Factor 8 inhibitors and the use of blood products in patients with haemophilia A.
    Ikkala E; Simonen O
    Scand J Haematol; 1971; 8(1):16-20. PubMed ID: 5566970
    [No Abstract]   [Full Text] [Related]  

  • 23. Anti-factor VIII inhibitors and lupus anticoagulants in haemophilia A patients.
    Blanco AN; Cardozo MA; Candela M; Santarelli MT; Pérez Bianco R; Lazzari MA
    Thromb Haemost; 1997 Apr; 77(4):656-9. PubMed ID: 9134638
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibitor to factor VIII in mild haemophilia.
    Lowe GD; Forbes CD
    Thromb Haemost; 1985 Feb; 53(1):159. PubMed ID: 3922079
    [No Abstract]   [Full Text] [Related]  

  • 25. Lupus anticoagulants and their relationship with the inhibitors against coagulation factor VIII: considerations on the differentiation between the 2 circulating anticoagulants.
    Tripodi A; Mancuso ME; Chantarangkul V; Clerici M; Bader R; Meroni PL; Santagostino E; Mannucci PM
    Clin Chem; 2005 Oct; 51(10):1883-5. PubMed ID: 16099933
    [No Abstract]   [Full Text] [Related]  

  • 26. [Problems posed by surgery in a hemophiliac with circulating anticoagulants. Apropos of 3 cases].
    Lareng L; Bierme R; Pris J; Bertrand JC
    Anesth Analg (Paris); 1975; 32(4):623-6. PubMed ID: 1227338
    [No Abstract]   [Full Text] [Related]  

  • 27. Simultaneous occurrence of lupus anticoagulant and factor VIII inhibitors in hemophilia.
    Blanco AN; Lazzari MA
    Am J Hematol; 1998 Jul; 58(3):248. PubMed ID: 9662281
    [No Abstract]   [Full Text] [Related]  

  • 28. Heterogeneity of human circulating anticoagulants against antihemophilic factor (factor VIII).
    Poon MC; Wine AC; Ratnoff OD; Bernier GM
    Blood; 1975 Sep; 46(3):409-16. PubMed ID: 50101
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Circulating anticoagulant in a family with prolonged bleeding time and factor VIII deficiency.
    Diez-Ewald M; Lian EC; Nunez R; Deykin D; Harkness DR
    Blood; 1977 May; 49(5):799-806. PubMed ID: 851643
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Factor VIII inhibitor and severity of hemophilia.
    Schoppmann A; Waytes AT
    Thromb Haemost; 1996 Aug; 76(2):280-1. PubMed ID: 8865549
    [No Abstract]   [Full Text] [Related]  

  • 31. [Successful induction of immune tolerance and novel hemostatic effects in a hemophilia A with high-responder inhibitor by regular infusions of factor VIII].
    Shima M; Sawamoto Y; Kamisue M; Shibata Y; Tuzi S; Kuwabara M; Tanaka I; Tanizawa T; Tanaka A; Ueda M; Kakishita E; Yoshioka A
    Rinsho Ketsueki; 1996 Nov; 37(11):1303-8. PubMed ID: 8960666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Immune coagulation disorders (excluding antiphospholipid syndrome].
    Arai M
    Rinsho Byori; 2001 Oct; 49(10):1000-4. PubMed ID: 11769464
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Protective effect of prophylaxis on inhibitor development in children with haemophilia A: more convincing studies are required.
    Calvez T; Laurian Y
    Br J Haematol; 2006 Mar; 132(6):798-800; author reply 800-1. PubMed ID: 16487187
    [No Abstract]   [Full Text] [Related]  

  • 34. Clinicohaematological profile of two cases of inhibitors to factor VIII.
    Shanthala Devi AM; Srikrishna A; Sitalaksmi S; Damodar P
    Indian J Pathol Microbiol; 2001 Jul; 44(3):365-6. PubMed ID: 12024937
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemophilia with factor VIII and factor IX inhibitors, incidence, bleeding problems and management.
    Mahasandana C; Patharathienskul D; Suvatte V
    Southeast Asian J Trop Med Public Health; 1993; 24 Suppl 1():106-12. PubMed ID: 7886549
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Transfusion problems in immunocoagulopathies].
    Lechner K; Stych H
    Bibl Haematol; 1971; 37():199-205. PubMed ID: 5138905
    [No Abstract]   [Full Text] [Related]  

  • 37. Circulating anticoagulant (antifactor 8 treated with immunosuppressive drugs.
    Sherman LA; Goldstein MA; Sise HS
    Thromb Diath Haemorrh; 1969 Apr; 21(2):249-58. PubMed ID: 5786668
    [No Abstract]   [Full Text] [Related]  

  • 38. [Appearance of a factor VIII inhibitor during the postoperative period in two non-hemophiliacs].
    Lévy G; Juhan I; Calas-Aillaud MF; Granthil G; Martin C; Verdot JJ; François G
    Ann Anesthesiol Fr; 1980; 21(5):545-9. PubMed ID: 6109504
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Factor VIII inhibitors].
    Albores Núñez MI; Pérez Llanderal JA; Telenti Vigón A
    Rev Clin Esp; 1968 Apr; 109(2):129-36. PubMed ID: 5739637
    [No Abstract]   [Full Text] [Related]  

  • 40. [Factor VIII, factor VIII inhibitor].
    Takamatsu J
    Nihon Rinsho; 1999 Sep; 57 Suppl():604-6. PubMed ID: 10543190
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.